In the Phase 3 EV-304 trial, statistically significant improvements in overall survival and pathological complete response were also observed, with over half of patients having no detectable disease ...
Pfizer Inc. and Astellas Pharma Inc. (TSE: 4503, President and CEO: Naoki Okamura, "Astellas") today announced positive results from the Phase 3 EV-304 clinical trial (also known as KEYNOTE-B15) for ...
Looking for a detailed training program that can help you reach your goals? Looking for a detailed training program that can help you reach your goals? Women's Health guides have helped women all over ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results